Neurocognitive evaluation of long term survivors of atypical teratoid rhabdoid tumors (ATRT): The Canadian registry experience

Pediatric Blood and Cancer

Volumn 62, Issue 7, 2015, Pages 1265-1269

  Lafay Cousin, Lucie ^a   Fay Mcclymont, Taryn ^a   Johnston, Donna ^b   Fryer, Chris ^c   Scheinemann, Katrin ^d   Fleming, Adam ^e   Hukin, Juliette ^c   Janzen, Laura ^f   Guger, Sharon ^f   Strother, Douglas ^a   Mabbott, Donald ^f   Huang, Annie ^f   Bouffet, Eric ^f  

^a ALBERTA CHILDREN'S HOSPITAL   (Canada)

^b CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^c Vancouver   (Canada)

^d MCMASTER UNIVERSITY   (Canada)

^e MONTREAL CHILDREN S HOSPITAL   (Canada)

^f HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

ATRT; Neurocognitive evaluation; Survivor

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; LOMUSTINE; METHOTREXATE; PREDNISONE; RETINOIC ACID; TAMOXIFEN; THIOTEPA; VINCRISTINE;

ACADEMIC ACHIEVEMENT; ARTICLE; ATYPICAL TERATOID RHABDOID TUMOR; CANADIAN; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CANCER SURVIVOR; CHILD; CHILDHOOD CANCER; CLINICAL ASSESSMENT; CONTROLLED STUDY; CRANIOSPINAL IRRADIATION; DRUG MEGADOSE; FEMALE; FOLLOW UP; FULL SCALE INTELLECTUAL QUOTIENT; HUMAN; INTELLIGENCE QUOTIENT; LANGUAGE ABILITY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MOTOR PERFORMANCE; MULTIMODALITY CANCER THERAPY; NEUROPSYCHOLOGY; OUTCOME ASSESSMENT; PERSONAL EXPERIENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SPATIAL MEMORY; STEM CELL TRANSPLANTATION; VERBAL MEMORY; VISUAL MEMORY; ADOLESCENT; BRAIN NEOPLASMS; CANADA; COGNITION DISORDERS; COMPLICATION; INFANT; NEUROPSYCHOLOGICAL TEST; NEWBORN; PRESCHOOL CHILD; PROGNOSIS; PSYCHOLOGY; REGISTER; RHABDOID TUMOR; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; SURVIVOR; TERATOMA;

ADOLESCENT; BRAIN NEOPLASMS; CANADA; CHILD; CHILD, PRESCHOOL; COGNITION DISORDERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; MALE; NEUROPSYCHOLOGICAL TESTS; PROGNOSIS; REGISTRIES; RETROSPECTIVE STUDIES; RHABDOID TUMOR; SURVIVAL RATE; SURVIVORS; TERATOMA;

EID: 84929509992     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.25441     Document Type: Article

References (16)

1. Strother DR, Lafay-Cousin L, Boyett JM, Burger P, Aronin P, Constine L, Duffner P, Kocak M, Kun LE, Horowitz ME, Gajjar A. Benefit from prolonged dose-intensive chemotherapy for infants with malignant brain tumors is restricted to patients with ependymoma: A report of the Pediatric Oncology Group randomized controlled trial 9233/34. Neuro Oncol 2014; 16:457-465.
2. Chi SN, Zimmerman MA, Yao X, Cohen KJ, Burger P, Biegel JA, Rorke-Adams LB, Fisher MJ, Janss A, Mazewski C, Goldman S, Manley PE, Bowers DC, Bendel A, Rubin J, Turner CD, Marcus KJ, Goumnerova L, Ullrich NJ, Kieran MW. Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor. J Clin Oncol 2009; 27:385-389.
3. Hilden JM, Meerbaum S, Burger P, Finlay J, Janss A, Scheithauer BW, Walter AW, Rorke LB, Biegel JA. Central nervous system atypicalteratoid/rhabdoid tumor: Results of therapy in children enrolled in a registry. J Clin Oncol 2004; 22:2877-2884.
4. Lafay-Cousin L, Hawkins C, Carret AS, Johnston D, Zelcer S, Wilson B, Jabado N, Scheinemann K, Eisenstat D, Fryer C, Fleming A, Mpofu C, Larouche V, Strother D, Bouffet E, Huang A. Central nervous system atypical teratoid rhabdoid tumours: The Canadian Paediatric Brain Tumour Consortium experience. Eur J Cancer 2012; 48:353-359.
5. Slavc I, Chocholous M, Leiss U, Haberler C, Peyrl A, Azizi AA, Dieckmann K, Woehrer A, Peters C, Widhalm G, Dorfer C, Czech T. Atypical teratoid rhabdoid tumor: Improved long-term survival with an intensive multimodal therapy and delayed radiotherapy. The Medical University of Vienna Experience 1992-2012. Cancer Med 2014; 3:1992-2012.
6. Ginn KF, Gajjar A. Atypical teratoid rhabdoid tumor: Current therapy and future directions. Front Oncol 2012; 2:114.
7. Chen YW1, Wong TT, Ho DM, Huang PI, Chang KP, Shiau CY, Yen SH. Impact of radiotherapy for pediatric CNS atypical teratoid/rhabdoid tumor (single institute experience). Int J Radiat Oncol Biol Phys 2006; 64:1038-1043.
8. Finkelstein-Shechter T, Gassas A, Mabbott D, Huang A, Bartels U, Tabori U, Janzen L, Hawkins C, Taylor M, Bouffet E. Atypical teratoid or rhabdoid tumors: Improved outcome with high-dose chemotherapy. J Pediatr Hematol Oncol 2010; 32:e182-6.
9. An KJ, Joung YS, Sung KW, Kim JH. Health-related quality of life and cognitive functioning at on- and off-treatment periods in children aged between 6-13 years old with brain tumors: A prospective longitudinal study. Yonsei Med J 2013; 54:6-13.
10. Gardner SL, Asgharzadeh S, Green A, Horn B, McCowage G, Finlay J. Intensive induction chemotherapy followed by high dose chemotherapy with autologous hematopoietic progenitor cell rescue in young children newly diagnosed with central nervous system atypical teratoid rhabdoid tumors. Pediatr Blood Cancer 2008; 51:235-240.
11. Mulhern RK, Palmer SL, Reddick WE, Glass JO, Kun LE, Taylor J, Langston J, Gajjar A. Risks of young age for selected neurocognitive deficits in medulloblastoma are associated with white matter loss. J Clin Oncol 2001; 19:472-479.
12. Rutkowski S, Bode U, Deinlein F, Ottensmeier H, Warmuth-Metz M, Soerensen N, Graf N, Emser A, Pietsch T, Wolff JE, Kortmann RD, Kuehl J. Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. N Engl J Med 2005; 352:978-8614.
13. Kadan-Lottick NS, Brouwers P, Breiger D, Kaleita T, Dziura J, Northrup V, Chen L, Nicoletti M, Bostrom B, Stork L, Neglia JP. Comparison of neurocognitive functioning in children previously randomly assigned to intrathecal methotrexate compared with triple intrathecal therapy for the treatment of childhood acute lymphoblastic leukemia. J Clin Oncol 2009; 27:5986-5992.
14. Conklin HM, Krull KR, Reddick WE, Pei D, Cheng C, Pui CH. Cognitive outcomes following contemporary treatment without cranial irradiation for childhood acute lymphoblastic leukemia. J Natl Cancer Inst 2012; 104:1386-1395.
15. Fay-McClymont T, Johnston D, Janzen L, Guger S, Scheinemann K, Fleming A, Fryer C, Hukin J, Mabbott D, Huang A, Bouffet E, Lafay-Cousin L. Long term neuropsychological follow up of young children with medulloblastoma treated according to the CCG 99703. Neuro Onc 2014;16 (suppl 1): i1-i 157.
16. Lafay-Cousin L, Payne E, Strother D, Chernos J, Chan M, Bernier FP. Goldenhar phenotype in a child with distal 22q11.2 deletion and intracranial atypical teratoid rhabdoid tumor. Am J Med Genet A 2009;149A: 1:2885-2889.